Literature DB >> 2417646

Concordance of a point mutation 5' to the A gamma-globin gene with A gamma beta + hereditary persistence of fetal hemoglobin in Greeks.

P G Waber, M A Bender, R E Gelinas, C Kattamis, A Karaklis, K Sofroniadou, G Stamatoyannopoulos, F S Collins, B G Forget, H H Kazazian.   

Abstract

In the Greek A gamma beta + type of hereditary persistence of fetal hemoglobin (HPFH), adult heterozygotes produce about 20% fetal hemoglobin (HbF), which is predominantly of the A gamma chain variety. The affected beta-globin gene cluster produces near normal amounts of beta-like globin, but in a A gamma to beta ratio of 20:80 instead of 0.5:99.5. Gelinas et al and Collins et al have shown a G to A change 117 nucleotides 5' to the A gamma gene in two Greeks with A gamma beta + HPFH. To demonstrate that this change is not a neutral polymorphism, we carried out hybridization with oligonucleotide probes (19mers) specific for the normal and the mutant sequences. While normal probe identified the A gamma fragment in genomic DNA of all subjects studied, mutant probe was positive only in Greeks with A gamma beta + HPFH. In sum, 108 beta-globin gene clusters of individuals without HPFH were negative when tested with mutant probe, but all 11 affected individuals of six families with Greek A gamma beta + HPFH (two previously sequenced and four new families) were positive with mutant probe. These data support the conclusion that the -117 mutation is causative of A gamma beta + HPFH in Greeks.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417646

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.

Authors:  S Ottolenghi; C Camaschella; P Comi; B Giglioni; M Longinotti; L Oggiano; F Dore; G Sciarratta; G Ivaldi; G Saglio
Journal:  Hum Genet       Date:  1988-05       Impact factor: 4.132

2.  The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.

Authors:  R Mantovani; N Malgaretti; S Nicolis; A Ronchi; B Giglioni; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

3.  A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.

Authors:  M W Rixon; R E Gelinas
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

4.  Analyses of linked beta-globin genes suggest that nondeletion forms of hereditary persistence of fetal hemoglobin are bona fide switching mutants.

Authors:  J E Metherall; F P Gillespie; B G Forget
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

5.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.

Authors:  D L Gumucio; K L Rood; T A Gray; M F Riordan; C I Sartor; F S Collins
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  A naturally occurring gamma globin gene mutation enhances SP1 binding activity.

Authors:  K Sykes; R Kaufman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

7.  Mutations in two regions upstream of the A gamma globin gene canonical promoter affect gene expression.

Authors:  J A Lloyd; R F Lee; J B Lingrel
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

8.  The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein.

Authors:  R Mantovani; G Superti-Furga; J Gilman; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

9.  The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.

Authors:  K D Fischer; J Nowock
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

Review 10.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.